Pediatric Neurology Briefs
Published 2006 | Version v1.0.0
Journal Article Open

Trial of Immune Globulin in Infant Botulism

Creators

Abstract

A 5-year, randomized, double-blind, placebo-controlled trial of the orphan drug Human Botulism Immune Globulin Intravenous (BIG-IV) in 122 infants in California with confirmed infant botulism (75 caused by type A Clostridium botulinum toxin, and 47 by type B toxin) was conducted at the California Department of Health Services, Richmond, CA; National Botulism Surveillance and Reference Laboratory, CDC and P, Atlanta; and Division of Biostatistics, University of California, Berkeley.

Files

PNB-20-13.pdf

Files (1.2 MB)

Name Size Download all
md5:559d3e7b38e3662ccd2e014873e37bc7
1.2 MB Preview Download

Additional details

Identifiers

Other
PNB-20-13

Dates

Created
2006
When the item was originally created.